Drugmakers Blamed for Blocking Generics Have Increased Prices, Cost US Billions Drugmakers Blamed for Blocking Generics Have Increased Prices, Cost US Billions

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016.Kaiser Health News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news